Global Sartans API Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Sartans API Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Sartans API report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Sartans API market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Anti-Hypertension and Anti-Viral are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Sartans API industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Sartans API key manufacturers include Pfizer, Novartis, Merck, AstraZeneca, Eli Lilly, Sanofi, Bristol-Myers Squibb, Bayer and GSK, etc. Pfizer, Novartis, Merck are top 3 players and held % sales share in total in 2022.
Sartans API can be divided into Valsartan, Irbesartan, Telmisartan and Losartan, etc. Valsartan is the mainstream product in the market, accounting for % sales share globally in 2022.
Sartans API is widely used in various fields, such as Anti-Hypertension, Anti-Viral and Others,, etc. Anti-Hypertension provides greatest supports to the Sartans API industry development. In 2022, global % sales of Sartans API went into Anti-Hypertension filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Sartans API market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report

Pfizer
Novartis
Merck
AstraZeneca
Eli Lilly
Sanofi
Bristol-Myers Squibb
Bayer
GSK
Teva Pharmaceutical
Xianju Pharma
Menovo
Tianyu Pharma
Starry Pharma
Huahai Pharmaceutical
Segment by Type
Valsartan
Irbesartan
Telmisartan
Losartan
Others
Anti-Hypertension
Anti-Viral
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Sartans API market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Sartans API, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Sartans API industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Sartans API in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Sartans API introduction, etc. Sartans API Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Sartans API market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
North America, Europe and Asia Pacific are the key regions for Sartans API industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Sartans API key manufacturers include Pfizer, Novartis, Merck, AstraZeneca, Eli Lilly, Sanofi, Bristol-Myers Squibb, Bayer and GSK, etc. Pfizer, Novartis, Merck are top 3 players and held % sales share in total in 2022.
Sartans API can be divided into Valsartan, Irbesartan, Telmisartan and Losartan, etc. Valsartan is the mainstream product in the market, accounting for % sales share globally in 2022.
Sartans API is widely used in various fields, such as Anti-Hypertension, Anti-Viral and Others,, etc. Anti-Hypertension provides greatest supports to the Sartans API industry development. In 2022, global % sales of Sartans API went into Anti-Hypertension filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Sartans API market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report

By Company
Pfizer
Novartis
Merck
AstraZeneca
Eli Lilly
Sanofi
Bristol-Myers Squibb
Bayer
GSK
Teva Pharmaceutical
Xianju Pharma
Menovo
Tianyu Pharma
Starry Pharma
Huahai Pharmaceutical
Segment by Type
Valsartan
Irbesartan
Telmisartan
Losartan
Others
Segment by Application
Anti-Hypertension
Anti-Viral
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Sartans API market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Sartans API, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Sartans API industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Sartans API in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Sartans API introduction, etc. Sartans API Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Sartans API market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
